These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 11884127

  • 21. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
    Monteiro RQ, Rapôso JG, Wisner A, Guimarães JA, Bon C, Zingali RB.
    Biochem Biophys Res Commun; 1999 Sep 07; 262(3):819-22. PubMed ID: 10471408
    [Abstract] [Full Text] [Related]

  • 22. Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.
    Martin PD, Malkowski MG, DiMaio J, Konishi Y, Ni F, Edwards BF.
    Biochemistry; 1996 Oct 08; 35(40):13030-9. PubMed ID: 8855938
    [Abstract] [Full Text] [Related]

  • 23. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor.
    Chirgadze NY, Sall DJ, Klimkowski VJ, Clawson DK, Briggs SL, Hermann R, Smith GF, Gifford-Moore DS, Wery JP.
    Protein Sci; 1997 Jul 08; 6(7):1412-7. PubMed ID: 9232642
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E, Elgendy S, Goodwin CA, Green D, Scully MF, Kakkar VV, Freyssinet JM, Dodson G, Deadman JJ.
    Biochemistry; 1998 Oct 13; 37(41):14420-7. PubMed ID: 9772168
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
    Malikayil JA, Burkhart JP, Schreuder HA, Broersma RJ, Tardif C, Kutcher LW, Mehdi S, Schatzman GL, Neises B, Peet NP.
    Biochemistry; 1997 Feb 04; 36(5):1034-40. PubMed ID: 9033393
    [Abstract] [Full Text] [Related]

  • 28. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
    Vijayalakshmi J, Padmanabhan KP, Mann KG, Tulinsky A.
    Protein Sci; 1994 Dec 04; 3(12):2254-71. PubMed ID: 7756983
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. New bivalent thrombin inhibitors with N(alpha)(methyl)arginine at the P1-position.
    Steinmetzer T, Batdordshjin M, Pineda F, Seyfarth L, Vogel A, Reissmann S, Hauptmann J, Stürzebecher J.
    Biol Chem; 2000 Jul 04; 381(7):603-10. PubMed ID: 10987367
    [Abstract] [Full Text] [Related]

  • 31. Structural analysis of thrombin complexed with potent inhibitors incorporating a phenyl group as a peptide mimetic and aminopyridines as guanidine substitutes.
    Bone R, Lu T, Illig CR, Soll RM, Spurlino JC.
    J Med Chem; 1998 Jun 04; 41(12):2068-75. PubMed ID: 9622548
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Conformational analysis of gamma' peptide (410-427) interactions with thrombin anion binding exosite II.
    Sabo TM, Farrell DH, Maurer MC.
    Biochemistry; 2006 Jun 20; 45(24):7434-45. PubMed ID: 16768439
    [Abstract] [Full Text] [Related]

  • 34. Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.
    Katz BA, Luong C.
    J Mol Biol; 1999 Sep 24; 292(3):669-84. PubMed ID: 10497030
    [Abstract] [Full Text] [Related]

  • 35. Secondary structure peptide mimetics: design, synthesis, and evaluation of beta-strand mimetic thrombin inhibitors.
    Boatman PD, Ogbu CO, Eguchi M, Kim HO, Nakanishi H, Cao B, Shea JP, Kahn M.
    J Med Chem; 1999 Apr 22; 42(8):1367-75. PubMed ID: 10212122
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Approaches to selective peptidic inhibitors of factor Xa.
    Bromfield KM, Quinsey NS, Duggan PJ, Pike RN.
    Chem Biol Drug Des; 2006 Jul 22; 68(1):11-9. PubMed ID: 16923021
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin.
    Maurer MC, Peng JL, An SS, Trosset JY, Henschen-Edman A, Scheraga HA.
    Biochemistry; 1998 Apr 28; 37(17):5888-902. PubMed ID: 9558322
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.